Emanant Pharma And Medical Technologies Private Limited. - Company Profile

It is a home appliances private limited company based in Cochin, Kerala, India, established in 2008.
2008 Cochin, Kerala, India Struck Off
Last Updated:
About Emanant Pharma And Medical Technologies Private Limited.

Emanant Pharma And Medical Technologies Private Limited., a struck off private limited company, was established on 31 January 2008 in Cochin, Kerala, India. Engaging in household goods within the home appliances sector, it holds CIN: U51397KL2008PTC021785. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Kevin Yan (Director), Vikram Nair (Director). Past directors included Kesavan Nair, Tripunithura Subramanian Rajagopalan. It is based at Cc 60/89 Mahakavigi Road, Cochin, Kerala, 682011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397KL2008PTC021785

  • Registration Number

    021785

  • Incorporation Date

    31 January 2008

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 18 Year, 21 Days
Company report

Emanant Pharma And Medical Technologies Private Limited.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Emanant Pharma And Medical Technologies Private Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Emanant Pharma And Medical Technologies Private Limited.?
Current Directors
Name Designation Appointment Date Status
Kevin Yan Director 20 Oct 2008 Current
Vikram Nair Director 15 Jul 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Nov 2008 Past
Pramod Abcsdd Director 07 Nov 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emanant Pharma And Medical Technologies.

Enhance accessibility to Emanant Pharma And Medical Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Emanant Pharma And Medical Technologies revenue growth over time
Emanant Pharma And Medical Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emanant Pharma And Medical Technologies?

Unlock access to Emanant Pharma And Medical Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Emanant Pharma And Medical Technologies?

Unlock and access historical data on people associated with Emanant Pharma And Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emanant Pharma And Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emanant Pharma And Medical Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emanant Pharma And Medical Technologies
Recent Activity within the Organization
  • Director Appointment

    Kevin Yan was appointed as a Director was appointed as a Director on 20 Oct 2008 & has been associated with this company since 17 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Vikram Nair was appointed as a Director was appointed as a Director on 15 Jul 2008 & has been associated with this company since 17 years 7 months . was documented.

  • Company Incorporation

    Emanant Pharma And Medical Technologies Private Limited. was registered on 31 Jan 2008 with Roc Ernakulam & aged 18 years 21 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Emanant Pharma And Medical Technologies Private Limited.?

The CIN of Emanant Pharma And Medical Technologies Private Limited. is U51397KL2008PTC021785.

Where is Emanant Pharma And Medical Technologies Private Limited. headquartered?

Emanant Pharma And Medical Technologies Private Limited. is headquartered at Cc 60/89 Mahakavigi Road, Cochin, Kerala, 682011.

When was Emanant Pharma And Medical Technologies Private Limited. incorporated?

Emanant Pharma And Medical Technologies Private Limited. was incorporated on 31 January 2008.

Who are the current directors of Emanant Pharma And Medical Technologies Private Limited.?

The current directors of Emanant Pharma And Medical Technologies Private Limited. are

What is the primary industry of Emanant Pharma And Medical Technologies Private Limited.?

The primary industry of Emanant Pharma And Medical Technologies Private Limited. is Home Appliances.

Is Emanant Pharma And Medical Technologies Private Limited. a listed company?

Emanant Pharma And Medical Technologies Private Limited. is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available